We describe a technique for measuring intestinal barrier integrity, whereby the rate of translocation of a fluorescently-tagged sugar of known size reflects the permeability of tissue-derived human intestinal colonoids.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
We describe a technique for measuring intestinal barrier integrity, whereby the rate of translocation of a fluorescently-tagged sugar of known size reflects the permeability of tissue-derived human intestinal colonoids.
The intestinal barrier is a critical site of regulation between luminal antigens and the host immune system, and its dysregulation is implicated in multiple gastrointestinal diseases. Intestinal organoids can be a useful tool to understand and model differences in intestinal barrier integrity. Here, we describe a protocol that uses human colonoids to quantify functional intestinal barrier differences by measuring the flux of fluorescent tracers across organoid monolayers. After growing monolayers to confluence, we add a fluorescent tracer, such as FITC-dextran, to the apical chamber and detect its translocation into the basolateral chamber over time. Increased translocation of the fluorescent tracer is reflective of a more permeable, or weaker, epithelial barrier. This protocol is an adaptable platform that allows evaluation of functional intestinal barrier differences across multiple conditions in parallel. Using variations of this protocol, one can assess transepithelial permeability to molecules of various size, shape, and chemical structure, as well as permeability differences in the context of isolated treatments or microenvironmental changes on the apical or basolateral sides of epithelial cells. This allows for a deeper understanding of the mechanism and treatment of barrier disruption in disease states.
The intestinal mucosa is a complex structure that plays an important role in regulating the contact between the metabolites, antigens, and microbes in the intestinal lumen and the immune system and enteric circulation. Intestinal epithelial cells are a key component of this system, and in healthy conditions, form a highly selective barrier. Transport across the epithelium can occur through multiple mechanisms: transcellular active or passive transport, paracellular pore or leak pathways regulated by tight junctions and adherens junctions. Whether any of these pathways can be used by a molecule to translocate across the epithelium is determined by the hydrophobicity, s....
Access restricted. Please log in or start a trial to view this content.
All samples were acquired and used in accordance with a protocol approved by the University of Colorado Institutional Review Board (IRB), protocol number 14-2012.
NOTE: All procedures in steps 1-3 should be done in a sterile biosafety cabinet with sterile technique. A schematic of the protocol is presented in Figure 1.
1. Establishment of human colonoids from frozen cultures
NOTE: Ensure all materials are ready in the biosafety cabinet before thawing cells to minimize exposure of thawed organoids to freezing medium. The protocol begins with ....
Access restricted. Please log in or start a trial to view this content.
Using this protocol, the permeability of healthy human colonoids in the presence and absence of inflammatory signaling was analyzed. Addition of a mixture of inflammatory cytokines, termed cytomix, which includes IFNγ, TNFα, and IL-1β (each at 10 ng/ml), has been previously shown to induce intestinal barrier dysfunction as measured by TEER in intestinal epithelial cell models20,27. We aimed to determine if this barrier dysfunction could be recapitulated using the.......
Access restricted. Please log in or start a trial to view this content.
This is a protocol to assess the intestinal barrier in the physiologically representative model of human colonoid monolayers. The fluorescent tracer flux assay described here provides information about the functional integrity of the barrier beyond what is gleaned with other types of barrier assays, such as TEER, Ussing chamber measurements, or evaluation of tight junction protein expression. Additionally, the use of patient-derived intestinal organoid models confers the benefit of recapitulating complex human physiology.......
Access restricted. Please log in or start a trial to view this content.
There are no disclosures or conflicts of interest.
Dr. Sean Colgan is funded by NIH grants DK1047893, DK50189, DK095491, DK103639, and VA Merit BX002182.
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| 15 mL conical centrifuge tubes | Celltreat | 229411 | |
| 2 mL Internal Threaded Cryogenic Vial | Corning | 430488 | |
| 50 mL conical centrifuge tubes | Celltreat | 229421 | |
| 6-well plate, tissue culture treated | Celltreat | 229106 | |
| 70 μm cell strainer | Falcon | 352350 | |
| 96-well black/clear bottom plate | Thermo Scientific | 165305 | |
| A83-01 | R&D | 2939 | |
| BioTek Synergy plate reader | Agilent | Synergy H1 | |
| Cellometer Auto T4 Brightfield cell counter | Nexcelcom | CMT-AT4P | |
| Cellometer cell counting chambers | Nexcelcom | NC1531583 | |
| CHIR99021 | Sigma-Aldrich | SML1046-5MG | |
| Collagen coating solution | Cell Applications | 125-50 | |
| DMEM/F-12 | Gibco | 11330057 | |
| DMSO | Sigma-Aldrich | D2650-100ML | |
| Ethanol 100% | Fisher Scientific | A4094 | |
| EVOM2 Voltohm Meter with Stx2 Electrode | World Precision Instruments | NC9792051 | |
| Fetal Bovine Serum (FBS) | Cytiva | SH30396.03HI | |
| Filter pipet tips | Fisher Scientific | 02-707-000, 02-707-002, 02-707-006, 02-707-008 | |
| Fluorescein isothiocyanate (FITC)-dextran, 4kDa | Sigma-Aldrich | 46944 | |
| Gastrin I (Human) | R&D | 3006 | |
| GlutaMAX | Fisher Scientific | 35050061 | 200 mM L-alanyl-L-glutamine dipeptide |
| Hanks buffered saline solution 10x | Thermo Scientific | 14065056 | |
| HEPES 1M | Thermo Scientific | 15630080 | |
| Interferon gamma recombinant human | BioLegend | 575308 | |
| Interleukin 1 beta recombinant human | Thermo scientific | 200-01B-500UG | |
| IntestiCult Intestinal Organoid Growth Medium (Human) | STEMCELL Technologies | 06010 | Commercial intestinal organoid media |
| Live inverted microscope | Olympus | IX85 | |
| Matrigel | Corning | 354234 | Extracellular matrix (ECM) |
| Microbiological incubator | Fisher Scientific | 151030515 | |
| Multiwell plate for suspension culture, 24 well | Greiner Bio-one | 662102 | |
| Nicotinamide | R&D | 4106 | |
| Parafilm | Millipore Sigma | HS234526B | Sealing film |
| Pasteur pipets (borosilicate glass) | Fisher Scientific | 13-678-20B | |
| PBS | Gibco | 10010-023 | |
| Penicillin Streptomycin (10,000 U/mL) | Gibco | 15140122 | |
| Recombinant moouse epidermal growth factor | R&D | 2028-EG | |
| Refrigerated centrifuge | Beckman Coulter | BE-AX15R | |
| SB202190 | R&D | 1264 | |
| Thiazovivin | R&D | 3845 | |
| ThinCert cell culture insert for 24 well plate, 0.4 μm | Greiner Bio-one | 662641 | |
| Trypsin-EDTA (0.25%) | Fisher Scientific | 25200114 | |
| Tumor necrosis factor alpha recombinant human | R&D | 10291-TA-100 | |
| Y-27632 dihydrochloride | Tocris | TB1254-GMP |
Access restricted. Please log in or start a trial to view this content.